Tirzepatide

Category: Dual GIP/GLP-1 receptor agonist

Studied or approved for: Type 2 diabetes (Mounjaro), chronic weight management (Zepbound)

Regulatory status: FDA-APPROVED (brand-name products). Compounded versions are NOT FDA-approved.

Typical administration: Weekly injection

Educational purposes only — not medical advice. Peptiverse.net does not sell or prescribe peptides. Consult a qualified healthcare professional. Full disclaimer: /disclaimer/.